ecancer news

Intensive chemotherapy may be harmful to most older patients with AML

Thu, 29 Jul 2010 12:06:01 GMT

The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukaemia (AML) is poor, with a median survival of less than six months, according to a study

New molecular marker could predict if breast cancer patients need chemotherapy

Wed, 28 Jul 2010 14:59:00 GMT

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists.

The study, part-funded

CTC screening for colorectal cancer not cost-effective when reimbursed at same rate as colonoscopy

Wed, 28 Jul 2010 14:35:08 GMT

Computed tomographic colonography, also known as virtual colonoscopy, is not cost-effective if reimbursed at the same rate as colonoscopy, according to a study published online July 27 in The J

Women in their forties have lower mammographic tumour detectability

Wed, 28 Jul 2010 10:00:49 GMT

The reduced effectiveness of mammographic screening in women in their forties is primarily due to lower detectability instead of faster tumour growth rate, according to a study published online Jul

Genetic risk score associated with breast cancer risk

Wed, 28 Jul 2010 10:00:02 GMT

Women with higher risk scores that consisted of having certain genetic variants most strongly linked to breast cancer had an associated higher risk of breast cancer, with these scores also highly p

New roundtable debate: communicating risk in familial cancer

Tue, 27 Jul 2010 15:47:50 GMT

The European commission funded project Eurocancercoms is looking at the information and communication needs of cancer professionals, patients, an

�50m fund for cancer drugs

Tue, 27 Jul 2010 13:36:24 GMT

UK cancer patients are to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund announced by UK Health Secretary Andrew Lansley today.

Study finds that the GRB7 gene drives an aggressive form of the disease

Tue, 27 Jul 2010 11:28:19 GMT

Oregon Health & Science University Knight Cancer Institute researchers have found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, kno

ASCO updates guideline on adjuvant hormonal therapy for breast cancer

Tue, 27 Jul 2010 11:25:58 GMT

The American Society of Clinical Oncology (ASCO) has recently issued a guideline update on the use of adjuvant hormone therapy for women with hormone receptor-positive breast cancer. The Update Com

NICE guideline set to improve care of cancer patients with unknown primary

Tue, 27 Jul 2010 11:23:35 GMT

Specialist cancer teams will be tasked with improving the care and treatment of patients whose cancer has spread to other parts of the body from an unknown primary location. The re-organisation of

Childhood cancer survivors may have abnormal long-term cardiac function

Tue, 27 Jul 2010 10:00:33 GMT

Childhood cancer survival is associated with increased risk of long-term abnormalities in cardiac function, according to a report in the July 26 issue of Archives of Internal Medicine, one

Most men with low-risk prostate cancer receive aggressive treatment

Tue, 27 Jul 2010 09:59:31 GMT

Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen (PSA) level and low-risk disease, according to a report

Abnormal circulating cells in lung cancer patients: possible new technique for identification

Fri, 23 Jul 2010 10:37:19 GMT

Researchers at The University of Texas M. D. Anderson Cancer Center are testing a new technique for identifying circulating genetically abnormal cells, which can lead to poor prognosis, in patients

Childhood cancer survivors face 'pregnancy risk'

Fri, 23 Jul 2010 10:10:35 GMT

Thanks to advances in medicine, many children and adolescents who were diagnosed with cancer years ago are now surviving to adulthood and wanting to start families themselves. But how does exposure

FDA panel says bevacizumab should not be used to treat advanced breast cancer

Wed, 21 Jul 2010 14:39:36 GMT

Genentech, a member of the Roche Group announced yesterday that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin (bevacizu

Scientists develop new genomics-based approach to understand origin of cancer subgroups

Tue, 20 Jul 2010 15:37:34 GMT

An international team led by St. Jude Children's Research Hospital scientists finds unique combinations of cells and mutations lie at the heart of cancer subgroup revealed for the first time in a p

Largest study of genomes and cancer treatments releases first results

Tue, 20 Jul 2010 10:37:53 GMT

The largest study to correlate genetics with response to cancer drugs has released its first results. The UK-US collaboration's work is a step towards more personalised cancer treatment.

Th

Breast cancer link to cleaning products

Tue, 20 Jul 2010 10:21:25 GMT

Women who report greater use of cleaning products may be at higher breast cancer risk than those who say they use them sparingly. Researchers writing in the open access journal

Inverse association between coffee intake and head and neck cancers

Sun, 18 Jul 2010 11:16:51 GMT

By Dr Sharan Sharma

A new study published online in Cancer Epidemiology, Biomarkers and Prevention (22nd July) showed an

Lower gastric cancer risk with NSAID use in Helicobacter infected patients

Sat, 17 Jul 2010 11:14:27 GMT

By Dr Sharan Sharma

Regular nonsteroidal anti-inflammatory drug (NSAID) use can be a feasible way to prevent cancer in Helicobacter pylori infected gastric ulcer patients according to a new

Telephone-based care management programme helps cancer patients with pain

Fri, 16 Jul 2010 11:59:25 GMT

Cancer patients receiving care in geographically dispersed urban and rural oncology practices who participated in a programme that included telephone-based care management and home-based automated

Non-cancer deaths increase with combined chemo/radiotherapy for regionally advanced nasopharyngeal carcinoma

Fri, 16 Jul 2010 11:22:57 GMT

Although the standard practice of treating patients with advanced Nasopharyngeal Carcinoma using radiation and chemotherapy may reduce cancer deaths compared to patients treated with radiation alon

Screening women for Factor V Leiden mutation before using tamoxifen

Fri, 16 Jul 2010 11:11:24 GMT

By Dr Sharan Sharma

Tamoxifen use in breast cancer is associated with increase in thromboembolic events (TEs). Factor V Lieden (FVL) mutation, the most common clotting factor mutation, is a

New breast cancer gene discovered

Thu, 15 Jul 2010 13:47:48 GMT

Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 9,000 UK women

Childhood cancer survivors have increased risk of death from second primary cancers

Wed, 14 Jul 2010 11:37:47 GMT

Follow-up of a group of British childhood cancer survivors indicates they have an increased risk of death from second primary cancers and cardiac and cerebrovascular causes more than 25 years after

Chronic Diseases Alliance urges EU action on chronic disease

Wed, 14 Jul 2010 11:10:11 GMT

In June the Chronic Diseases Alliance presented a document to John Dalli, the EU Commissioner for Health and Consumer Policy setting out their strategy for tackling chronic diseases. The Chronic Di

Cancer survival figures 'double'

Mon, 12 Jul 2010 12:05:46 GMT

People diagnosed with breast, bowel and ovarian cancers and non-Hodgkin's lymphoma are today twice as likely to survive for at least 10 years as those diagnosed in the early 1970s according to new

Fish oil may reduce risk of breast cancer

Fri, 9 Jul 2010 10:49:47 GMT

A recent report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Resear

ESMO publishes updated guidelines on cancer care

Thu, 8 Jul 2010 09:34:35 GMT

The European Society for Medical Oncology (ESMO) has released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.

Length of biological marker associated with risk of cancer

Wed, 7 Jul 2010 13:31:32 GMT

A new study suggests that shorter length of leukocyte telomeres - chromosome markers of biological aging - are associated with an increased risk of cancer and death from cancer, according to a stud

Men with faulty gene may carry breast cancer risk

Tue, 6 Jul 2010 14:59:10 GMT

Men who carry a faulty BRCA2 gene have a 1 in 15 chance of developing breast cancer by the time they reach 70, suggests the largest study of its kind, published online in the The genomic analyses of a diverse sample of soft-tissue sarcomas - cancer that develops in connective tissue - is reported this week in

ASCO 2010: The Roundup

Fri, 2 Jul 2010 14:56:35 GMT

By freelance medical journalist Rhonda Siddall

The 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) wa

Virgin olive oil linked to protection against breast cancer by a number of mechanisms

Thu, 1 Jul 2010 16:54:03 GMT

Researchers at Universitat Autònoma de Barcelona, led by Dr Eduard Escrich, have discovered a key mechanism by which virgin olive oil, in contrast to other vegetable oils, protects the b

NIH and Wellcome Trust launch partnership to support population-based genome studies in Africa

Wed, 30 Jun 2010 14:49:21 GMT

The National Institutes of Health (NIH), an agency of the US Department of Health and Human Services, and the Wellcome Trust, a global charity based in London, have announced a partnership to suppo

Excess weight linked to increased risk of dying from cancer in populations of Asia-Pacific

Wed, 30 Jun 2010 00:10:46 GMT

Overweight and obese individuals from the Asia-Pacific region are significantly more likely to die from cancer compared with individuals in the normal weight range. New strategies are urgently need

Fewer than half of breast cancer patients adhere to hormonal therapy regimen

Tue, 29 Jun 2010 11:39:19 GMT

A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half – approximately 49 percent – completed their full regimen of hormone therapy accordin

EACR news: Furry mice and bricklayers: more jobs for telomerases

Mon, 28 Jun 2010 10:44:03 GMT

Elizabeth Blackburn inaugurates EACR 21st meeting and gives a broader outlook on these enzymes.

By Silvia Camporesi

The classic perspective on telomerases,

Forum Against Cancer Europe (FACE) launched in the European Parliament

Fri, 25 Jun 2010 10:32:13 GMT

On 23 June a new initiative of the European Cancer Patient Coalition (ECPC) entitled Forum Against Cancer Europe (FACE) was successfully launched at the European Parliament. The Forum A

EU authorises new therapeutic indication of Tyverb

Thu, 24 Jun 2010 16:27:00 GMT

GlaxoSmithKline (GSK) confirmed yesterday that the European Commission has granted a variation to the conditional marketing authorisation for Tyverb (lapatinib) in the European Union for a new ther

Your views on open access publishing are needed.

Wed, 23 Jun 2010 11:57:16 GMT

The SOAP Project*, funded by the European Commission, would like to announce the release of an online survey to assess researchers' experiences with open access publishing. This survey aims to info

Ten year data confirms the early and long-term benefits of anastrozole over tamoxifen

Tue, 22 Jun 2010 15:48:46 GMT

120 month follow-up data from the landmark ATAC trial demonstrate that the benefits of anastrozole over tamoxifen start early and continue up to five years after treatment completion in postm

Pfizer withdraws AML drug from US market

Tue, 22 Jun 2010 11:49:27 GMT

Pfizer announced yesterday that based on discussions with the US Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg (gemtuzumab ozogamicin), used for t

New collaboration in anti-cancer stem cell therapeutics targets Wnt signalling pathway

Mon, 21 Jun 2010 09:31:56 GMT

A new alliance to discover, develop and commercialise novel anti-cancer stem cell therapeutics targeting the Wnt signalling pathway has been launched.

Under the terms of the agreement, Baye

Surveillance may be suitable treatment option for patients with low-risk prostate cancer

Mon, 21 Jun 2010 09:28:39 GMT

Active surveillance or watchful waiting might be sufficient treatment for patients with prostate cancer that has a low risk of progression, according to a new study published online June 18 in

Gene mutation increases thromboembolism risk in women taking tamoxifen

Fri, 18 Jun 2010 12:28:40 GMT

Women taking tamoxifen for early-stage breast cancer who developed blood clots were more likely to carry a gene mutation for clotting than women taking tamoxifen who did not develop a clot, acco